Related Experiment Video
Updated: Feb 17, 2026
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Sensitivity of the Medication Possession Ratio to Modelling Decisions in Large Claims Databases
Margret V Bjarnadottir1, David Czerwinski2, Eberechukwu Onukwugha3
1Department of Decision, Operations, and Information Technologies, Robert H. Smith School of Business, University of Maryland College Park, College Park, MD, USA.
Objectives:
When preparing administrative medical and pharmacy claims data for analysis, decisions about data clean up and analytical approach need to be made. However, information about the effects of various modelling decisions on adherence measures such as the medication possession ratio (MPR) is limited. We address this gap with this study.
Methods:
We utilized cross-sectional administrative claims data for commercially insured members filling at least two prescriptions for drugs within five classes of hypertension medication between 2008 and 2010. We divided nine modelling decisions into three categories: data scrubbing, study design, and MPR definition/calculations. We defined the base-case settings with commonly used values, varied each modelling decision singly and in combination, and measured the effects on the MPR.
Results:
Claims data for 358,418 individuals were available for analysis. Two modelling decisions were found to be highly influential, each yielding a difference of over 25 percentage points from the base case: the decision of whether to use interval- or prescription-based study periods, and the decision of how to handle overlapping prescription claims. The effect of other decisions was smaller, with a difference of 1-9 percentage points from the base case.
Conclusions:
Some of the decisions considered had a large impact on the MPR. Therefore, it is important for researchers to standardize approaches for study period length and overlapping prescription claims. We also conclude that transparent reporting of modelling decisions will facilitate the interpretation of results and comparisons across studies.
More Related Videos
Related Concept Videos
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
01:23Mechanistic Models: Compartment Models in Individual and Population Analysis
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...